Fighting TB with Artificial Intelligence
The challenge of tuberculosis is multi-sided: it demands a diagnostic solution that is affordable, quick, accurate and easy to implement in underdeveloped regions. We utilize artificial intelligence that allows tuberculosis to be diagnosed with unprecedented speed and ease.
TB Affects Millions of People
Tuberculosis is a major and complicated challenge that affects nearly 10 million people every year. If it is diagnosed in time, TB is generally curable within 6 months. Unfortunately, about one-third of patients fail to receive a quick, accurate diagnosis or effective treatment, making them more likely to die from this curable disease. With 1.5 million deaths in 2020, TB is the second most prevalent infectious cause of death.
If diagnosed in time, TB is curable within 6 months.
Solving the problem of tuberculosis requires a diagnostic solution that is affordable, quick, accurate and easy to implement in underdeveloped regions.
Delft addresses the difficulties of TB diagnosis by combining the speed and low costs of digital X-ray with the powerful capacities of machine learning and big data
The weakest link in the fight against TB
is reinforcing diagnosis
The diagnostic standard for countries with a significant TB burden is formed by the sputum smear microscopy and the GeneXpert MTB-RIF test (GXP). However, the low sensitivity of the smear test and the high costs of a GXP test have led the World Health Organization (WHO) to recommend the use of digital chest X-rays and CAD for systematic TB screening.
X-ray imagery can show abnormalities in the lungs that suggest a patient may have TB. Digital X-ray also has the advantage of low operational cost and quick results, so it can improve TB diagnosis. However, X-rays still require local expertise for accurate reading, and that expertise is often lacking in TB-ridden areas.
Our Solutions Improve Quality of Life
Delft Imaging is dedicated to improving people’s quality of life around the world by delivering innovative systems, software and services
CAD4TB Software
Most validated CAD available: recommended by the WHO
World’s first CAD software for TB screening. Designed to help non-experts detect and diagnose TB more accurately and cost-effectively. CAD4TB is recommended by the WHO and is currently used in over 45 countries, screening over 9,6 million people globally.
OneStopTB Clinics
All-in-one solution for fighting Tuberculosis
As all-in-one mobile solutions, Delft’s OneStopTB clinics reach remote, and frequently underserviced, areas with ease. The clinic is equipped with Delft’s CAD4TB technology, x-rays and more, and is designed to diagnose and treat TB in a self-sustaining unit.
X-Ray Systems
Multifunctional systems, fully compatible to CAD4TB
Delft provides a complete range of affordable and reliable diagnostic equipment that is specifically made to perform under challenging conditions. This range includes our portable Delft Ultra & Delft Light systems, and our Stationary EasyDR system for larger screening programs.